Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.


Journal

World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 23 11 2018
medline: 25 6 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

Therapeutic lateral neck dissection (ND) is recommended for N1b papillary thyroid carcinoma (PTC), while prophylactic contralateral lateral ND is not. Given the paucity of data, we investigated the frequency of and risk factors for occult lymph node metastases (LNM) in the contralateral lateral neck for N1b patients. This is a retrospective study conducted at a cancer center. Inclusion criteria were: unilateral PTC and ipsilateral lateral LNM confirmed by fine-needle aspiration biopsy. Patients with contralateral lateral LNM or bilateral tumor on ultrasound were excluded. All patients were treated with total thyroidectomy, bilateral central ND, ipsilateral therapeutic lateral ND and prophylactic contralateral ND of levels III-IV, followed by radioactive iodine. Sixty-three patients met the inclusion criteria. Occult contralateral lateral LNM were found in 23/63 patients (36.5%) who had more LNM in ispilateral (p = .01) and contralateral level VI (p < .0001), more frequent microscopic tumor in the contralateral lobe (p = .017) and a trend toward being at high risk (p = .06). Using receiver operating characteristic analysis, a cutoff of >4 LNM in ipsilateral level VI optimized sensitivity and specificity for predicting contralateral lateral LNM, with a sensitivity of 74%, specificity of 65%, positive predictive value of 55% and negative predictive value of 81%. Neck recurrence occurred in 14%, with only 1 patient recurring only in the contralateral lateral neck (1.5%). Occult LNM in the contralateral lateral neck was found in 36.5% of patients. Five or more ipsilateral central LNM may aid in predicting contralateral lateral LNM, and high-risk patients may be more at risk. The clinical benefit of prophylactic contralateral lateral ND remains doubtful, however.

Identifiants

pubmed: 30465086
doi: 10.1007/s00268-018-4862-9
pii: 10.1007/s00268-018-4862-9
doi:

Substances chimiques

Iodine Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-823

Références

Arch Otolaryngol Head Neck Surg. 2008 May;134(5):536-8
pubmed: 18490577
Endocr J. 2009;56(2):177-92
pubmed: 18703852
World J Surg. 2008 Nov;32(11):2494-502
pubmed: 18784956
Thyroid. 2009 Nov;19(11):1153-8
pubmed: 19860578
Thyroid. 2010 Dec;20(12):1341-9
pubmed: 21034228
World J Surg. 2012 Mar;36(3):593-7
pubmed: 22207493
World J Surg. 2012 Jun;36(6):1274-8
pubmed: 22270990
World J Surg Oncol. 2012 Oct 25;10:221
pubmed: 23098385
Thyroid. 2013 Sep;23(9):1099-105
pubmed: 23421588
Ann Surg Oncol. 2014 May;21(5):1647-52
pubmed: 24385210
Ann Surg Oncol. 2015 Oct;22(11):3530-6
pubmed: 25665952
PLoS One. 2015 Jul 17;10(7):e0133625
pubmed: 26186205
Surgery. 2016 Mar;159(3):755-62
pubmed: 26435440
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
Surgery. 2016 Jun;159(6):1565-1571
pubmed: 26994486

Auteurs

Hélène Bohec (H)

Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Ingrid Breuskin (I)

Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Julien Hadoux (J)

Department of Medical Imaging, Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Martin Schlumberger (M)

Department of Medical Imaging, Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Sophie Leboulleux (S)

Department of Medical Imaging, Nuclear Medicine and Endocrine Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France.

Dana M Hartl (DM)

Department of Head and Neck Oncology, Gustave Roussy, Université Paris-Saclay, 114 rue Edouard Vaillant, 94805, Villejuif, France. dana.hartl@gustaveroussy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH